Radek Spisek

Radek Spisek

Company: SOTIO

Job title: Chief Executive Officer


SOT102: Claudin 18.2 Targeting PNU-based ADC for the Treatment of Gastric & Pancreatic Cancer 4:45 pm

Differentiated ADC targeting CLDN18.2 with novel proprietary antibody Built on NBE Therapeutics iADC platform: PNU toxin, sortase-mediated coupling Recruitment of the Phase I trial to start in March 2022Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.